Continuum of Care for Hodgkin Lymphoma: Impact of Modern Therapy on Postacute Morbidity and Mortality.
作者信息
Evens Andrew M, Parsons Susan K
机构信息
Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.
Departments of Pediatrics and Medicine, Tufts University School of Medicine; and Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA.
出版信息
J Clin Oncol. 2020 Dec 10;38(35):4131-4134. doi: 10.1200/JCO.20.02668. Epub 2020 Oct 8.
Abstract
摘要
相似文献
1
Continuum of Care for Hodgkin Lymphoma: Impact of Modern Therapy on Postacute Morbidity and Mortality.
J Clin Oncol. 2020 Dec 10;38(35):4131-4134. doi: 10.1200/JCO.20.02668. Epub 2020 Oct 8.
2
Brentuximab vedotin (replased/refractory Hodgkin lymphoma and CD30 positive non-Hodgkin lymphoma.
Gan To Kagaku Ryoho. 2015 May;42(5):550-2.
3
The Changing Landscape of Lymphoma Associated with HIV Infection.
Curr Oncol Rep. 2020 Aug 15;22(11):111. doi: 10.1007/s11912-020-00973-0.
4
Does Radiation Have a Role in Advanced Stage Hodgkin's or Non-Hodgkin Lymphoma?
Curr Treat Options Oncol. 2016 Jan;17(1):4. doi: 10.1007/s11864-015-0377-x.
5
Epidemiology, outcome, targeted agents and immunotherapy in adolescent and young adult non-Hodgkin and Hodgkin lymphoma.
Br J Haematol. 2019 Jun;185(6):1142-1157. doi: 10.1111/bjh.15789. Epub 2019 Feb 6.
6
Caring beyond cure: quality of life after high-dose chemotherapy for patients with relapsed Hodgkin lymphoma.
Leuk Lymphoma. 2010 Nov;51(11):1949-50. doi: 10.3109/10428194.2010.512967.
7
Checkpoint Inhibitors and Other Immune Therapies for Hodgkin and Non-Hodgkin Lymphoma.
Curr Treat Options Oncol. 2016 Jun;17(6):31. doi: 10.1007/s11864-016-0401-9.
8
Bone marrow transplantation for Hodgkin's disease and lymphoma.
Annu Rev Med. 1993;44:255-63. doi: 10.1146/annurev.me.44.020193.001351.
9
[Methylhydrazine in the therapy of malignant lymphopathies].
Policlinico Prat. 1967 Jan 16;74(3):82-5.
10
[Standard treatment of malignant lymphoma (Hodgkin's and non-Hodgkin's lymphoma)].
Nihon Naika Gakkai Zasshi. 2001 Jun 10;90(6):997-1002. doi: 10.2169/naika.90.997.
引用本文的文献
1
Newly Diagnosed Classical Hodgkin Lymphoma: Optimizing Outcomes in a New Therapeutic Era.
Hematol Oncol. 2025 Jun;43 Suppl 2(Suppl 2):e70066. doi: 10.1002/hon.70066.
2
Harnessing multi-source data for individualized care in Hodgkin Lymphoma.
Blood Rev. 2024 May;65:101170. doi: 10.1016/j.blre.2024.101170. Epub 2024 Jan 14.
3
The Advanced-Stage Hodgkin Lymphoma International Prognostic Index: Development and Validation of a Clinical Prediction Model From the HoLISTIC Consortium.
J Clin Oncol. 2023 Apr 10;41(11):2076-2086. doi: 10.1200/JCO.22.02473. Epub 2022 Dec 10.
4
Informing radiotherapy decisions in stage I/IIa Hodgkin lymphoma: modeling life expectancy using radiation dosimetry.
Blood Adv. 2022 Feb 8;6(3):909-919. doi: 10.1182/bloodadvances.2021006254.
本文引用的文献
1
Cause-Specific Mortality Following Initial Chemotherapy in a Population-Based Cohort of Patients With Classical Hodgkin Lymphoma, 2000-2016.
J Clin Oncol. 2020 Dec 10;38(35):4149-4162. doi: 10.1200/JCO.20.00264. Epub 2020 Sep 18.
2
How I treat advanced Hodgkin lymphoma - a global view.
Br J Haematol. 2020 Sep;190(6):837-850. doi: 10.1111/bjh.16587. Epub 2020 Jun 19.
3
Advancing age and the risk of bleomycin pulmonary toxicity in a largely older cohort of patients with newly diagnosed Hodgkin Lymphoma.
J Geriatr Oncol. 2020 Jan;11(1):69-74. doi: 10.1016/j.jgo.2019.09.009. Epub 2019 Oct 24.
4
Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma.
Blood. 2019 Oct 10;134(15):1238-1246. doi: 10.1182/blood.2019000719.
5
Therapeutic recommendations for early stage Hodgkin lymphomas.
Br J Haematol. 2019 Jan;184(1):9-16. doi: 10.1111/bjh.15623. Epub 2018 Nov 28.
6
Current treatment paradigms for advanced stage Hodgkin lymphoma.
Br J Haematol. 2019 Jan;184(1):60-71. doi: 10.1111/bjh.15622. Epub 2018 Nov 8.
7
Patient and physician preferences for first-line treatment of classical Hodgkin lymphoma in Germany, France and the United Kingdom.
Br J Haematol. 2019 Jan;184(2):202-214. doi: 10.1111/bjh.15566. Epub 2018 Sep 21.
8
Early-stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long-term patient outcomes.
Br J Haematol. 2018 Jul;182(2):212-221. doi: 10.1111/bjh.15255. Epub 2018 Apr 29.
9
The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE).
Lancet. 2017 Dec 9;390(10112):2569-2582. doi: 10.1016/S0140-6736(17)31610-0. Epub 2017 Sep 8.
10
Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial.
J Clin Oncol. 2017 Jun 1;35(16):1786-1794. doi: 10.1200/JCO.2016.68.6394. Epub 2017 Mar 14.
Zotero 插件